Intravenous or inhaled salbutamol in severe acute asthma?
Journal: 1978/February - Thorax
ISSN: 0040-6376
PUBMED: 594935
Abstract:
Ten patients with life-threatening attacks of asthma (status asthmatiucus') were treated with salbutamol inhaled by intermittent positive pressure breathing, and their response in terms of rise in peak flow rate was measured. They were then given intravenous salbutamol and any further increment in peak flow was measured. Hydrocortisone treatment was started simultaneously and the responses to salbutamol were re-measured on each of the next three days. Only two patients initially responded to the aerosol, whereas all save one responded to the intravenous drug. The two who responded initially to the aerosol were the two who were able to produce sputum at the time of admission. All patients subsequently responded to the aerosol, and the onset of this response correlated closely with the beginning of sputum production. Sympathominetics should be given parenterally to patients in severe asthma if the response to inhaled drug is reduced or absent.
Relations:
Content
Citations
(22)
References
(11)
Diseases
(1)
Conditions
(1)
Drugs
(11)
Chemicals
(1)
Organisms
(1)
Similar articles
Articles by the same authors
Discussion board
Thorax 32(5): 555-558

Intravenous or inhaled salbutamol in severe acute asthma?

Abstract

Ten patients with life-threatening attacks of asthma (status asthmatiucus') were treated with salbutamol inhaled by intermittent positive pressure breathing, and their response in terms of rise in peak flow rate was measured. They were then given intravenous salbutamol and any further increment in peak flow was measured. Hydrocortisone treatment was started simultaneously and the responses to salbutamol were re-measured on each of the next three days. Only two patients initially responded to the aerosol, whereas all save one responded to the intravenous drug. The two who responded initially to the aerosol were the two who were able to produce sputum at the time of admission. All patients subsequently responded to the aerosol, and the onset of this response correlated closely with the beginning of sputum production. Sympathominetics should be given parenterally to patients in severe asthma if the response to inhaled drug is reduced or absent.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (489K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Choo-Kang YF, Parker SS, Grant IW. Response of asthmatics to isoprenaline and salbutamol aerosols administered by intermittent positive-pressure ventilation. Br Med J. 1970 Nov 21;4(5733):465–468.[PMC free article] [PubMed] [Google Scholar]
  • Collins JV, Clark TJ, Brown D, Townsend J. The use of corticosteroids in the treatment of acute asthma. Q J Med. 1975 Apr;44(174):259–273. [PubMed] [Google Scholar]
  • COOKSON DU, REED CE. A COMPARISON OF THE EFFECTS OF ISOPROTERENOL IN THE NORMAL AND ASTHMATIC SUBJECT. A PRELIMINARY REPORT. Am Rev Respir Dis. 1963 Nov;88:636–643. [PubMed] [Google Scholar]
  • Ellul-Micallef R, Fenech FF. Effect of intravenous prednisolone in asthmatics with diminished adrenergic responsiveness. Lancet. 1975 Dec 27;2(7948):1269–1271. [PubMed] [Google Scholar]
  • Fitchett DH, McNicol MW, Riordan JF. Intravenous salbutamol in management of status asthmaticus. Br Med J. 1975 Jan 11;1(5949):53–55.[PMC free article] [PubMed] [Google Scholar]
  • HUME KM, GANDEVIA B. Forced expiratory volume before and after isoprenaline. Thorax. 1957 Sep;12(3):276–278.[PMC free article] [PubMed] [Google Scholar]
  • MacDonald JB, MacDonald ET, Seaton A, Williams DA. Asthma deaths in Cardiff 1963-74: 53 deaths in hospital. Br Med J. 1976 Sep 25;2(6038):721–723.[PMC free article] [PubMed] [Google Scholar]
  • Macdonald JB, Seaton A, Williams DA. Asthma deaths in Cardiff 1963-74: 90 deaths outside hospital. Br Med J. 1976 Jun 19;1(6024):1493–1495.[PMC free article] [PubMed] [Google Scholar]
  • Rebuck AS, Read J. Assessment and management of severe asthma. Am J Med. 1971 Dec;51(6):788–798. [PubMed] [Google Scholar]
  • Shenfield GM, Hodson ME, Clarke SW, Paterson JW. Interaction of corticosteroids and catecholamines in the treatment of asthma. Thorax. 1975 Aug;30(4):430–435.[PMC free article] [PubMed] [Google Scholar]
  • Williams SJ, Parrish RW, Seaton A. Comparison of intravenous aminophylline and salbutamol in severe asthma. Br Med J. 1975 Dec 20;4(5998):685–685.[PMC free article] [PubMed] [Google Scholar]
Abstract
Ten patients with life-threatening attacks of asthma (status asthmatiucus') were treated with salbutamol inhaled by intermittent positive pressure breathing, and their response in terms of rise in peak flow rate was measured. They were then given intravenous salbutamol and any further increment in peak flow was measured. Hydrocortisone treatment was started simultaneously and the responses to salbutamol were re-measured on each of the next three days. Only two patients initially responded to the aerosol, whereas all save one responded to the intravenous drug. The two who responded initially to the aerosol were the two who were able to produce sputum at the time of admission. All patients subsequently responded to the aerosol, and the onset of this response correlated closely with the beginning of sputum production. Sympathominetics should be given parenterally to patients in severe asthma if the response to inhaled drug is reduced or absent.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.